**Specifications table**TableSubject area*Biology.*More specific subject area*Nanobiotechnology.*Type of data*Tables and images.*How data was acquired*Images were acquired with transmission electron microscope JEOL JEM-2100 (JEOL Ltd.) and size distributions were acquired using dynamic light scattering method with Zetasizer Nano ZS analyzer (Malvern Instruments, Ltd.).*Data format*Raw and analyzed.*Experimental factors*Magnetite nanoparticles were synthesized by coprecipitation of iron salts FeCl*~*2*~*and FeCl*~*3*~*and stabilized with the fusion protein of Barstar and C-term part of Mms6 protein in concentrations ranging from 0.3 µM to 40 µM.*Experimental features*The nanoparticle properties were studied by transmission electron microscopy and dynamic light scattering.*Data source location*Moscow, Russia.*Data accessibility*All data are presented in this article.*

**Value of the data**•The data demonstrate the significant change in the hydrodynamic size distribution of nanoparticles after the incubation with Bs-C-Mms6 protein.•The data shows that 5 µM of Bs-C-Mms6 protein is enough to stabilize the uncoated Fe~3~O~4~ magnetic nanoparticles at concentration of 0.5 g/L in water.•The data may be relevant for other researchers using fusion proteins containing Mms6 for magnetic nanoparticle stabilization, modification and application for cell culture experiments.•The data may be relevant for further studies that focus on the use of such biofunctionalized nanoparticles for *in vivo* tumor cell targeting.

1. Data {#s0005}
=======

In this report, we summarize data on characterization of magnetite nanoparticles stabilized with fusion protein of Barstar and C-term part of Mms6 (Bs-C-Mms6) designed in the study [@bib1]. We studied the morphology of the synthesized nanoparticles with transmission electron microscopy and characterized the change of hydrodynamic size distribution of nanoparticles after the incubation with different concentrations of Bs-C-Mms6 as well as with other non-specific proteins, such as pristine Barstar, Bs and bovine serum albumin, BSA.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Materials {#s0015}
--------------

Sigma, Germany: Iron (III) Chloride hexahydrate (FeCl~3~·6H2O), Iron (II) Chloride tetrahydrate (FeCl~2~·4H~2~O), Ammonium hydroxide solution (NH~4~OH), Nitric acid (HNO~3~). All other chemical reagents were of analytical grade and were used without further purification.

2.2. Magnetic nanoparticle synthesis {#s0020}
------------------------------------

Nanoparticles of magnetite (MPs) were synthesized similar to described by us earlier [@bib2] with the following modifications. 2.36 g of FeCl~3~·6H~2~O and 0.86 g of FeCl~2~·4H~2~O (2.15 g) were dissolved in 40 mL of MilliQ water. Then, 5 mL of 30% NH~4~OH was added. The solution was heated to 90 °C for 2 h with constant stirring. The resulted magnetite nanoparticles were separated with 30-mm Nd-Fe-B magnet and incubated in 2 M HNO~3~ for 5 min at RT. Then, resulted MPs were sequentially separated from HNO~3~ with MilliQ water. Each separation step included the addition of 10 mL of MilliQ water with the application the magnet to the bottom of the tube for 5 min. The separation steps were repeated 5 times, the fifth fraction was used for further modification.

2.3. Nanoparticle characterization with transmission electron microscopy {#s0025}
------------------------------------------------------------------------

As obtained MPs were studied by transmission electron microscopy at JEM-2100 (JEOL, Ltd.) with an accelerating voltage of 200 kV. The morphology of the obtained MPs corresponds to monocrystalline nanoparticles with a close to spherical shape with the average diameter of 10.9 ± 1.9 nm, the size was obtained as the result of electron microphotograph processing (see [Fig. 1](#f0005){ref-type="fig"}).Fig. 1Transmission electron microscopy of magnetite nanoparticles obtained with co-precipitation of iron salts. The particles are characterized with a close to spherical shape and by the mean diameter of 10.9 ± 1.9 nm.Fig. 1

2.4. Dynamic light scattering {#s0030}
-----------------------------

The hydrodynamic size of the synthesized MP was measured with Zetasizer Nano ZS analyzer (Malvern Instruments, Ltd.) in water at 25 °C. The measurements showed the hydrodynamic diameter of the particles to be 79.9 nm (PdI width is 31.8 nm). Such a significant difference of TEM physical size and hydrodynamic size could be explained by the formation of the hydration shell on the surface of the particles in water, which significantly affects the dynamic light scattering measurements.

2.5. Nanoparticle stabilization with Bs-C-Mms6 {#s0035}
----------------------------------------------

Fe~3~O~4~ magnetic nanoparticles obtained as described above were washed trice with MilliQ water and resuspended in MilliQ water to get a final concentration of 0.5*g*/L. Then, MPs were incubated with Bs-C-Mms6 protein (at final concentrations of protein from 0.3 µM to 40 µM) for 8 h at RT with occasional sonication in an ultrasonic bath RK 31H (Bandelin Sonorex) to get MP\*Bs-C-Mms6 particles. Next, particles were washed with MilliQ water from non-bound protein by triple centrifugation for 10 min at 20,000*g*, +4 °C in the desktop centrifuge 5430R (Eppendorf). Finally, particles were resuspended in phosphate buffered saline (PBS) in order to study their stability in buffered solutions. Bovine serum albumin (BSA) and Barstar (Bs) proteins were used instead of Bs-C-Mms6 for control experiments to get MP\*BSA and MP\*Bs particles.

The hydrodynamic size distribution of the modified nanoparticles was measured with Zetasizer Nano ZS in water at concentration of 0.1 g/L. The average sizes (*Z*-average) and PdI widths are presented in [Table 1](#t0005){ref-type="table"} for all modified nanoparticles.Table 1Hydrodynamic sizes of Fe~3~O~4~ nanoparticles incubated with Bs-C-Mms6, Bs and BSA proteins.Table 1Particle notation**MP\*Bs-C-Mms6MP\*BsMP\*BSA**Concentration of protein, µM*Z*-averagePdI Width*Z*-averagePdI Width*Z*-averagePdI Width40838.6440.2109.538.9103.832.920396.8151.8137.347.1108.632.810352.6153.2116.741.4102.834.65136.538.4111.039.596.735.42.5126.144.9114.033.5107.643.01.2598.637.986.832.5105.743.30.62586.331.793.834.885.733.80.312589.835.472.130.1133.877.0079.931.879.931.879.931.8

The significant increase in the size of MP\*Bs-C-Mms6 can be observed when the nanoparticles were incubated with the Bs-C-Mms6 protein in concentration more than 2.5 µM. However, only particles incubated with Bs-C-Mms6 in concentrations of protein higher than 5 µM exhibited excellent colloidal stability in PBS for a long period of time (2 months, no further observations were made). The use of control proteins, namely, BSA and Bs in the whole range of tested concentrations, did not result in the stabilization of the nanoparticles in the PBS: the particles precipitated in PBS within a few minutes (see [Fig. 2](#f0010){ref-type="fig"}).Fig. 2Colloidal stability of magnetite nanoparticles modified with Bs-C-Mms6 protein in phosphate buffered solution (PBS). Particles were incubated with 5 µM of Bs-C-Mms6, Bs or BSA and then transferred to PBS. Only MP\*BS-C-Mms6 exhibit excellent colloidal stability in PBS for a long period of time (up to 2 month).Fig. 2

According to the technology of Nanoparticle Tracking Analysis, NTA (NanoSight NS300, Malvern Instruments Ltd.) the mass concentration of the synthesized MP of 0.5 g/L corresponds to the molar concentration of MP equal to (0.9 ± 0.1)·10^−8^ М. This means that approximately 500 molecules of Bs-C-Mms6 protein are enough for stabilization of one nanoparticle in PBS.
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